This page is the continuation of references in support of Section 2F.
REFERENCES
Detterbeck FC, Boffa DJ, Tanoue LT. (2009). The new lung cancer staging system. Chest 136(1), 260–71. (Retrieved 22nd Jan 2015): http://journal.publications.chestnet.org/article.aspx?articleid=1089923
Dewan NA, Reeb SD, Gupta NC, Gobar LS, Scott WJ. (1995). PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. Chest. 108(2), 441–446. (Retrieved 5th Feb 2015): http://journal.publications.chestnet.org/article.aspx?articleid=1068887
De Wever W. (2009). Role of integrated PET/CT in the staging of non-small cell lung cancer. JBR-BTR. 92(2),124-6. (Retrieved 26th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed?term=19534253
Fischer B, Lassen U, Mortensen J, et al. (2009). Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 361(1), 32. (Retrieved 26th Feb 2015):
Heang-Ping C, Lubomir H, Chuan Z, Berkman S. (2010) Computer-Aided Diagnosis of Lung Cancer and Pulmonary Embolism in Computed Tomography — A Review. Acad Radiol. Author manuscript; available in PMC Jan 2. (Retrieved 9 th April 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800985/
Herder GJ, Kramer H, Hoekstra OS, et al, POORT Study Group. (2006).Traditional versus up-front [18F]fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol. 24(12), 1800-6. Epub 2006 Mar 27. (Retrieved 29th Jan 2015): http://jco.ascopubs.org/content/24/12/1800.long
Maziak DE, Darling GE, Inculet RI, et al. (2009). Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med 151(4), 221. (Retrieved 26th Feb 2015): http://annals.org/article.aspx?articleid=744660
Morgensztern D, Goodgame B, Baggstrom M, et al. (2008). The effect of FDG-PET on the stage distribution of non-small cell lung cancer. J Thorac Oncol 3, 135-139. (Retrieved 26th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/18303433
Schwartz AM, Rezaei MK. (2013). Diagnostic surgical pathology in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 143(5 Suppl), e251S-62S. (Retrieved 29th Jan 2015): http://journal.publications.chestnet.org/article.aspx?articleid=1685831
Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML,Gould MK, Tanoue LT, Harris LJ, Detterbeck FC. (2013) Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest.May;143(5 Suppl):e211S-50S. doi: 10.1378/chest.12-2355. (Retrieved 9th April 2015): http://www.ncbi.nlm.nih.gov/pubmed/23649440
van Tinteren H, Hoekstra OS, Smit EF, et al. (2002). Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359(9315), 1388. (Retrieved 29th Jan 2015): http://www.ncbi.nlm.nih.gov/pubmed?term=11978336
Verhagen AF, Bootsma GP, Tjan-Heijnen VC, et al. (2004). FDG-PET in staging lung cancer: how does it change the algorithm? Lung Cancer 44(2), 175-81. (Retrieved 26th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed?term=15084382
Zwirewich CV, Vedal S, Miller RR, Müller NL. (1991) Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology May: Volume 179, Issue 2. (Retrieved 30th Jan 2015): https://www.ncbi.nlm.nih.gov/pubmed/2014294
